Clinical significance of serum total sialic acid in cholangiocarcinoma

Clinica Chimica Acta

Volumn 327, Issue 1-2, 2003, Pages 139-147

  Wongkham, Sopit ^a   Bhudhisawasdi, Vajarabhongsa ^a   Chau in, Siri ^a   Boonla, Chanchai ^a   Muisuk, Kanha ^a   Kongkham, Supranee ^b   Wongkham, Chaisiri ^a   Boonsiri, Patcharee ^a   Thuwajit, Peti ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

CA19 9; Cholangiocarcinoma; Serum; Sialic acid; Tumor markers

Indexed keywords

ALKALINE PHOSPHATASE; CA 19-9 ANTIGEN; MUCIN; PERIODATE; SIALIC ACID; THIOBARBITURIC ACID; N ACETYLNEURAMINIC ACID; TUMOR MARKER;

ADULT; AGE; ARTICLE; BILE DUCT CARCINOMA; BLOOD ANALYSIS; BLOOD GROUP; BODY MASS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR LOCALIZATION; AGED; BLOOD; CHEMISTRY; MIDDLE AGED; PROGNOSIS; SURVIVAL;

AGED; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 1842867199     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00371-6     Document Type: Article

References (38)

1. Sonmez H., Suer S., Gungor Z., Baloglu H., Kokoglu E. Tissue and serum sialidase concentrations in breast cancer. Cancer Lett. 136:1999;75-78.
2. Schutter E.M., Visser J.J., van Kamp G.J., Mensdorff-Pouilly S., van Dijk M., Hilgers J.et al. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature. Tumour Biol. 13:1992;121-132.
3. Feijoo C., Paez de la Cadena M., Rodriguez-Berrocal F.J., Martinez-Zorzano V.S. Sialic acid concentrations in serum and tissue from colorectal cancer patients. Cancer Lett. 112:1997;155-160.
4. Erbil K.M., Sen S.E., Zincke H., Jones J.D. Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies. Cancer. 57:1986;1389-1394.
5. Tewarson S.L., Mittal V.P., Singh M., Gupta G.P. Serum sialic acid - an important cancer marker. Indian J. Cancer. 30:1993;125-131.
6. Verazin G., Riley W.M., Gregory J., Tautu C., Prorok J.J., Alhadeff J. A serum sialic acid and carcinoembryonic concentrations in the detection and monitoring of colorectal cancer. Dis. Colon Rectum. 33:1990;139-142.
7. Gatchev O., Rastam L., Lindberg G.et al. Tumors of the central nervous system and serum sialic acid concentration in men and women. Br. J. Cancer. 68:1993;425-427.
8. Patel P.S., Adhvaryu S.G., Balar D.B., Parikh B.J., Shah P.M. Clinical application of serum concentrations of sialic acid, fucose and seromucoid fraction as tumor markers in human leukemias. Anticancer Res. 14:1994;747-751.
9. Ros-Bullon M.R., Sanchez-Pedreno P., Martinez-Liarte J.H. Serum sialic acid in malignant melanoma patients: an ROC curve analysis. Anticancer Res. 19:1999;3619-3622.
10. Patel P.S., Raval G.N., Rawal R.M.et al. Comparison between serum concentrations of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Neoplasma. 42:1995;271-274.
11. Berbic H., Paszkowska A., Siwek B., Gradziel K., Cybulski M. Total serum sialic acid concentration as a supporting marker of malignancy in ovarian neoplasia. Eur. J. Gynaecol. Oncol. 20:1999;389-392.
12. Paszkowska A., Berbec H., Semczuk A., Cybulski M. Sialic acid concentration in serum and tissue of endometrial cancer patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 76:1998;211-215.
13. Vivas I., Spagnuolo L., Palacios P. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix. Gynecol. Oncol. 46:1992;157-162.
14. Romppanen J., Eskelinen M., Tikanoja S., Mononen I. Total and lipid-bound serum sialic acid in benign and malignant breast disease. Anticancer Res. 17:1997;1249-1253.
15. Wongkham S., Boonla C., Kongkham S., Wongkham C., Bhudhisawasdi V., Sripa B. Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. Clin. Biochem. 34:2001;537-541.
16. Narayanan S. Sialic acid as a tumor marker. Ann. Clin. Lab. Sci. 24:1994;376-384.
17. Stefenelli N., Klotz H., Engel A., Bauer P. Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J. Cancer Res. Clin. Oncol. 109:1985;55-59.
18. Turner G.A., Skillen A.W., Buamah P., Guthrie D., Welsh J., Harrison J.et al. Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers. J. Clin. Pathol. 38:1985;588-592.
19. Crook M. The determination of plasma or serum sialic acid. Clin. Biochem. 26:1993;31-38.
20. Sheehan J.K., Brazeau C., Kutay S., Pigeon H., Kirkham S., Howard M.et al. Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem. J. 347 Pt. 1:2000;37-44.
21. Mabry E.W., Carubelli R. Sialic acid in human cancer. Experientia. 28:1972;182-183.
22. Suer S., Sonmez H., Karaaslan I., Baloglu H., Kokoglu E. Tissue sialic acid and fibronectin concentrations in human prostatic cancer. Cancer Lett. 99:1996;135-137.
23. Maity P. Sialic acid in cervical carcinoma patients. Eur. J. Gynaecol. Oncol. 8:1987;102-104.
24. Dall'Olio F., Malagolini N., di Stefano G., Minni F., Marrano D., Serafin-Cessi F. Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues. Int. J. Cancer. 44:1989;434-439.
25. Kim Y.S., Isaacs R., Perdomo J.M. Alterations of membrane glycopeptides in human colonic adenocarcinoma. Proc. Natl. Acad. Sci. U. S. A. 71:1974;4869-4873.
26. Liu H.P., Yan Z.S., Zhang S.S. The application of leukocyte adherence inhibition assay to patients with colorectal cancer. Comparison with serum concentration of carcinoembryonic antigen and sialic acid. Dis. Colon Rectum. 32:1989;210-213.
27. Rokicki M., Rokicki W., Czyzewski K., Wojcieszek E. Usefulness of determining the concentrations of sialic acid in the blood serum, pulmonary homogenates and urine of patients with lung cancer. Nowotwory. 37:1987;226-231.
28. Sillanaukee P., Ponnio M., Jaaskelainen I.P. Occurrence of sialic acids in healthy humans and different disorders. Eur. J. Clin. Invest. 29:1999;413-425.
29. Ganzinger U., Deutsch E. Serum sialyltransferase concentrations as a parameter in the diagnosis and follow-up of gastrointestinal tumors. Cancer Res. 40:1980;1300-1304.
30. Griffiths J., Reynolds S. Plasma sialyl transferase total and isoenzyme activity in the diagnosis of cancer of the colon. Clin. Biochem. 15:1982;46-48.
31. Yonezawa S., Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol. Int. 47:1997;813-830.
32. Sasaki M., Nakanuma Y., Ho S.B., Kim Y.S. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Am. J. Clin. Pathol. 109:1998;302-308.
33. Kim Y.S., Gum J.R. Jr. Diversity of mucin genes, structure, function, and expression. Gastroenterology. 109:1995;999-1001.
34. Sasaki M., Nakanuma Y. Expression of mucin core protein of mammary type in primary liver cancer. Hepatology. 20:1994;1192-1197.
35. Wongkham S, Sheehan JK, Boonla C, Patrakitkomjorn S, Howard M, Kirkham S, et al. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. Cancer Lett. [in press].
36. Enss M.L., Cornberg M., Wagner S., Gebert A., Henrichs M., Eisenblatter R.et al. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm. Res. 49:2000;162-169.
37. Nichols J.C., Gores G.J., LaRusso N.F., Wiesner R.H., Nagorney D.M., Ritts R.E. Jr.et al. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin. Proc. 68:1993;874-879.
38. Obayashi Y., Fujita J., Nishiyama T., Yoshinouchi T., Kamei T., Yamadori I.et al. Role of carbohydrate antigens sialyl Lewis (a) (CA19-9) in bronchoalveolar lavage in patients with pulmonary fibrosis. Respiration. 67:2000;146-152.